MHLW Japan Discussing How To Bring Relief To Female Doctors

MHLW Japan has released a summary of its report on how female doctors, often working very long hours, can balance their family and work life.

Japan’s ministry of health, labour and welfare has released a summary of its report on how female doctors, often working very long hours, can balance their family and work life. In 2014, 32% of successful candidates in the national medical exam were women, indicating that this number is increasing. However, roughly 10% of female doctors who give birth stop working due to irregular working schedules, long hours, and difficulties in utilizing the maternity leave system, according to a recent Japan Medical Association survey. As part of the country’s overall economic growth strategy, the Cabinet decided in June that improvements must be made to female doctors’ conditions to prevent doctor shortages. A government committee focusing on female doctor concerns will meet for the first time to discuss solutions on August 8. (Click Here For More – Japanese Language

)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Japan

Japan Pharma Sees US Revenues Grow But Policy Impact Still Unclear

 
• By 

Japanese majors put in generally solid performances in the fiscal year ended 31 March, but overseas revenues and forex effects, rather than the domestic market, provided most of the growth.

Multiple Launches Help Lilly’s Japan Growth

 
• By 

Lilly saw solid growth for its business in Japan last year on the back of several new launches and is building its obesity and Alzheimer's portfolios in the country.

Shionogi In $1bn Deal For Japan Tobacco’s Pharma Ops

 
• By 

Mid-sized Japanese pharma firm to acquire tobacco giant’s pharma operations and take private the listed Torii Pharmaceutical business, in bid to build sales reach and strengthen manufacturing.

Japan Market Entry: Consortium’s One-Stop Shop To Support Foreign Entrants

 
• By 

Japanese CDMO Bushu talks about a consortium designed to provide a broad range of development services to smaller foreign firms looking to bring high-need drugs to the Japanese market.

More from Focus On Asia

Pharma Women’s Workforce In India: Weak Start, Promotions, C-Suite Drop Off

 

McKinsey senior partner Vivek Pandit talks to Scrip about some of the intricacies underlying the key findings of a study on pharma’s workforce gender gap in India. Women’s representation starts low at entry level, peaks at senior manager positions and falls off again for C-suite roles, this found.

Zydus To Continue Mirabegron Sales, Looks To World-First Dual Shigella-Typhoid Vaccine

 
• By 

Zydus expects strong mirabegron sales in FY26 amid US litigation even as it builds a growth pillar in vaccines with a world-first, Gates Foundation-aided dual shigella-typhoid vaccine under development and others on the WHO prequalified list

Japan Pharma Sees US Revenues Grow But Policy Impact Still Unclear

 
• By 

Japanese majors put in generally solid performances in the fiscal year ended 31 March, but overseas revenues and forex effects, rather than the domestic market, provided most of the growth.